Haselmeier Self-Injection Devices

Haselmeier specialises in the development and manufacture of innovative self-injection devices with proprietary designs and technology.

The company covers all of the steps in the creation of its award-winning devices from design, to planning and industrialisation.

Haselmeier also offers a range of early-stage development activities to ensure all products are high quality. The company conducts human factors studies and consults with user focus groups to provide successful administration. This is combined with a qualified design control process, certified quality system, regulatory expertise, a solid network of partners, and strong manufacturing operations designed to meet and exceed client expectations.

Self-injection devices for the pharmaceutical industry

Haselmeier has a world-class design and development team that works in compliance with regulatory requirements. The company creates, designs and industrialises self-injection systems used by pharmaceutical and biotechnology companies worldwide.

Haselmeier creates products to enable a convenient and comfortable experience, which is why patient feedback is integrated into device designs.

Concept and prototype evaluations for pharmaceutical devices

Early concepts are prototyped for testing to ensure high-quality products, while human factor studies capture the handling needs and skills of potential users.

This knowledge is integrated into the design of pharmaceutical devices to provide successful administration of drug products and optimal user experience.

Haselmeier offers a range of early stage activities, including:

  • Think-tank discussions and paper concepts for medical devices
  • Detailed product concepts and industrial designs for pharmaceuticals
  • User handling review and risk-analysis
  • Prototyping initial concepts up to functional devices for patients
  • User focus groups and human factor studies for concept and prototype evaluations
  • In-depth user requirements and design specifications based on a selected medical concept

Development of pharmaceutical devices depends on the understanding of technical, regulatory and operational requirements.

Design-to-manufacturing transfer services

Haselmeier offers integrated design, development and industrialisation services to help clients bridge their serial product into the market.

The company’s qualified design control process, certified quality system, regulatory expertise, network of partners and manufacturing operations are designed to help clients achieve their goals.

Haselmeier’s commercial development and industrialisation services include:

  • Concept transfer into user requirements and product design specifications for the pharmaceutical industry
  • Design verification, product and process validation processes
  • Regulatory expertise to support an approval strategy
  • Controlled design-to-manufacturing transfer, verification and validation of self-injection devices

Haselmeier applies the highest standards for manufacturing drug delivery devices to ensure reliable manufacturing and quality processes. The company works with customers to identify product improvements at all stages of its lifecycle, to provide a safe drug delivery device.

Haselmeier provides flexible manufacturing and lifecycle management, including:

  • Certified production facilities and manufacturing processes
  • Qualified and trained personnel
  • A strong network of sub-suppliers and manufacturing partners in the pharmaceutical sector
  • Continuous engineering and product improvement programme for medical devices
  • Innovation meetings to identify next product generation

About Haselmeier

Haselmeier develops and manufactures innovative self-injection devices that feature company designs and state-of-the-art technology.

Haselmeier has more than four decades of experience in the field of medical devices. Through the years, the company has built up a top-class planning and development team that is responsible for the design, planning and industrialisation of its innovative self-injection systems. The company manufactures successful products that are used by pharmaceutical and biotechnology companies worldwide.

Headquartered in Switzerland, Haselmeier employs around 200 people worldwide. The company has sales offices in Europe, the US and India. Haselmeier’s products are manufactured in state-of-the-art production facilities in Buchen, Odenwald, Dnešice and Bengaluru.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

Haselmeier Acquires Drug Manufacturing Licence and Now Offers Assembly, Labelling Packaging Services

As an innovative, strategic partner company, Haselmeier develops and produces customisd, unique systems that are used worldwide.  

Product and Services
White Papers

Self-Injection Device – The New D-Flex

The D-Flex injection pen can do more than previous pens. D-Flex can be configured for several fixed-dose values and is thus a variable fixed-dose pen.

Wilhelm Haselmeier GmbH & Co. KG

Vaihinger Strasse 48

70567 Stuttgart


+49 711 71 97 90 +49 711 71 78 71 www.haselmeier.com/de www.connected.haselmeier.com

Haselmeier Images


Press Release

11 February 2019

As an innovative, strategic partner company, Haselmeier develops and produces customisd, unique systems that are used worldwide.  

Read more
3 May 2018

Haselmeier and smart injector monitoring and support solutions company Common Sensing have announced a partnership agreement to develop smart connected monitoring and support solutions for users of injectable medicines.

Read more
15 November 2017

Konrad Betzler was appointed the new chief quality officer (CQO) of the entire Haselmeier  Group in October 2017, with responsibility for quality management, quality assurance, and all  regulatory matters worldwide.

Read more
22 August 2017

The Haselmeier D-Flex is a disposable pen for use with 3ml cartridges.

Read more
16 August 2017

The new Pergoveris® Pen by Haselmeier has received a positive assessment by Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA).

Read more
13 March 2017

Haselmeier has announced Paul Jansen has been appointed as its senior advisor and member of the board of directors.

Read more
3 March 2017

Haselmeier has announced that its new product the D-Flex Just one has won the GOOD DESIGN™ Award.

Read more
7 September 2016

After winning the GOOD DESIGN™ Award and the Red Dot Award: Product Design in 2015, Haselmeier has also been crowned winner of the German Brand Award 2016.

Read more
18 May 2016

Following approval by the European Medicines Agency (EMA), GONAL-f® 2.0 was launched by Haselmeier and Merck following its original release in 2011.

Read more
21 December 2015

Haselmeier has added connectivity to its devices portfolio with the announcement of its Axis-D-Connect disposable pen injector.

Read more

Regional Offices

Wilhelm Haselmeier GmbH & Co. KG

Vaihinger Strasse 48

70567 Stuttgart


+49 711 71 97 90 +49 711 71 78 71 www.haselmeier.com/de www.connected.haselmeier.com
Haselmeier AG

Albisriederstrasse 253 (YOND)

8047 Zurich


+41 44 250 52 40 +41 44 250 52 49 www.haselmeier.com/de
Haselmeier Inc

126 John Street

Lowell, MA 01852

United States of America

+1 978 252 3700 +1 978 710 3207 www.haselmeier.com/de www.connected.haselmeier.com
Haselmeier India Private Limited

J.R Tech Park, Building No.1, Sy No. 27/4 A2

Yarandahalli, Bommasandra 4th Phase

Jigani Hobli, Anekal Taluk

Bangalore – 560 105


+49 711 71 97 90 +49 711 71 78 71 www.haselmeier.com/de www.connected.haselmeier.com

Contact company

I have read and accept the terms and conditions and privacy policies.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.


Go Top